Loading clinical trials...
Loading clinical trials...
Epigenetic Changes as Prognostic Markers in Patients With Early Stage Non-Small Cell Lung Cancer
Conditions
Interventions
DNA methylation analysis
polymerase chain reaction
+1 more
Start Date
July 1, 2010
Primary Completion Date
January 1, 2014
Completion Date
January 1, 2014
Last Updated
July 6, 2016
NCT07486219
NCT07485114
NCT05198830
NCT06498635
NCT06066138
NCT07336732
Lead Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions